ALPS Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-66,403
| Closed | -$1.28M | – | 1036 |
|
2024
Q3 | $1.28M | Buy |
66,403
+110
| +0.2% | +$2.12K | 0.01% | 439 |
|
2024
Q2 | $1.36M | Buy |
66,293
+6,369
| +11% | +$131K | 0.01% | 397 |
|
2024
Q1 | $1.43M | Buy |
59,924
+11,798
| +25% | +$281K | 0.01% | 410 |
|
2023
Q4 | $1.04M | Sell |
48,126
-3,110
| -6% | -$67.2K | 0.01% | 468 |
|
2023
Q3 | $744K | Buy |
51,236
+651
| +1% | +$9.45K | 0.01% | 540 |
|
2023
Q2 | $1.06M | Buy |
50,585
+5,496
| +12% | +$115K | 0.01% | 480 |
|
2023
Q1 | $952K | Sell |
45,089
-317
| -0.7% | -$6.7K | 0.01% | 482 |
|
2022
Q4 | $1.16M | Buy |
45,406
+14,554
| +47% | +$370K | 0.01% | 420 |
|
2022
Q3 | $741K | Sell |
30,852
-2,504
| -8% | -$60.1K | 0.01% | 529 |
|
2022
Q2 | $642K | Sell |
33,356
-23,180
| -41% | -$446K | 0.01% | 540 |
|
2022
Q1 | $983K | Sell |
56,536
-1,643
| -3% | -$28.6K | 0.01% | 315 |
|
2021
Q4 | $1.27M | Sell |
58,179
-1,414
| -2% | -$31K | 0.01% | 329 |
|
2021
Q3 | $1.14M | Sell |
59,593
-3,948
| -6% | -$75.5K | 0.01% | 378 |
|
2021
Q2 | $1.09M | Buy |
+63,541
| New | +$1.09M | 0.01% | 395 |
|
2018
Q4 | – | Sell |
-41,328
| Closed | -$334K | – | 931 |
|
2018
Q3 | $334K | Buy |
41,328
+5,477
| +15% | +$44.3K | ﹤0.01% | 888 |
|
2018
Q2 | $252K | Buy |
35,851
+3,139
| +10% | +$22.1K | ﹤0.01% | 893 |
|
2018
Q1 | $465K | Buy |
32,712
+5,686
| +21% | +$80.8K | ﹤0.01% | 633 |
|
2017
Q4 | $237K | Buy |
27,026
+5,143
| +24% | +$45.1K | ﹤0.01% | 782 |
|
2017
Q3 | $256K | Buy |
21,883
+2,030
| +10% | +$23.7K | ﹤0.01% | 741 |
|
2017
Q2 | $277K | Buy |
+19,853
| New | +$277K | ﹤0.01% | 731 |
|
2016
Q4 | – | Sell |
-22,669
| Closed | -$344K | – | 730 |
|
2016
Q3 | $344K | Sell |
22,669
-2,310
| -9% | -$35.1K | ﹤0.01% | 633 |
|
2016
Q2 | $246K | Buy |
+24,979
| New | +$246K | ﹤0.01% | 591 |
|